KMG Fiduciary Partners LLC increased its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 2.8% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 79,977 shares of the company's stock after acquiring an additional 2,141 shares during the period. KMG Fiduciary Partners LLC's holdings in Cardinal Health were worth $9,459,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently modified their holdings of CAH. Dimensional Fund Advisors LP increased its holdings in Cardinal Health by 6.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,237,338 shares of the company's stock worth $121,664,000 after acquiring an additional 69,934 shares in the last quarter. Citizens Financial Group Inc. RI purchased a new stake in shares of Cardinal Health during the second quarter worth about $232,000. E Fund Management Co. Ltd. increased its stake in shares of Cardinal Health by 8.4% during the second quarter. E Fund Management Co. Ltd. now owns 2,054 shares of the company's stock worth $202,000 after purchasing an additional 159 shares in the last quarter. Mercer Global Advisors Inc. ADV raised its position in shares of Cardinal Health by 7.2% during the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 26,078 shares of the company's stock worth $2,564,000 after purchasing an additional 1,761 shares during the last quarter. Finally, Amalgamated Bank lifted its stake in Cardinal Health by 4.3% in the 2nd quarter. Amalgamated Bank now owns 71,339 shares of the company's stock valued at $7,014,000 after buying an additional 2,959 shares in the last quarter. Hedge funds and other institutional investors own 87.17% of the company's stock.
Cardinal Health Stock Performance
Shares of NYSE:CAH traded down $0.39 during trading on Friday, hitting $126.64. The company's stock had a trading volume of 881,432 shares, compared to its average volume of 2,050,790. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $127.27. The business has a 50 day moving average price of $120.63 and a two-hundred day moving average price of $111.61. The company has a market capitalization of $30.65 billion, a PE ratio of 24.64, a P/E/G ratio of 1.48 and a beta of 0.63.
Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Friday, November 1st. The company reported $1.88 EPS for the quarter, topping the consensus estimate of $1.62 by $0.26. The firm had revenue of $52.28 billion during the quarter, compared to analysts' expectations of $50.90 billion. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. Cardinal Health's revenue for the quarter was down 4.3% on a year-over-year basis. During the same period in the previous year, the firm posted $1.73 EPS. As a group, equities analysts expect that Cardinal Health, Inc. will post 7.82 earnings per share for the current fiscal year.
Cardinal Health Cuts Dividend
The company also recently announced a quarterly dividend, which was paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd were issued a $0.5056 dividend. The ex-dividend date was Thursday, January 2nd. This represents a $2.02 annualized dividend and a yield of 1.60%. Cardinal Health's dividend payout ratio (DPR) is 39.30%.
Wall Street Analysts Forecast Growth
CAH has been the subject of a number of research analyst reports. StockNews.com cut Cardinal Health from a "strong-buy" rating to a "buy" rating in a report on Sunday, November 3rd. Barclays increased their price objective on Cardinal Health from $117.00 to $133.00 and gave the company an "overweight" rating in a research note on Monday, November 4th. Morgan Stanley lifted their target price on shares of Cardinal Health from $127.00 to $136.00 and gave the stock an "overweight" rating in a research note on Tuesday, December 17th. Evercore ISI upgraded shares of Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 target price for the company in a research report on Tuesday, January 7th. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on shares of Cardinal Health from $119.00 to $124.00 and gave the stock a "hold" rating in a research report on Monday, November 4th. Four investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $133.29.
Check Out Our Latest Research Report on Cardinal Health
Cardinal Health Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
See Also
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
